多尼培南中間體

價(jià)格	詢價(jià)
包裝	As requirement

最小起訂量	As requirement
發(fā)貨地	北京
更新日期	2023-05-15

產(chǎn)品詳情

中文名稱:多尼培南中間體	英文名稱:(2S,4R)-2-(hydroxymethyl)-4-[(methylsulfonyl)oxy]-1-Pyrrolidinecarboxylic acid,(4-nitrophenyl)methyl ester (Doripenem side-chain intermediate); 4-Nitrobenzyl(2S,4S)-4-acetylthio-2-[[N-sulfamoyl-N-(tert-butoxycarbonyl)amino]methyl]pyrrolidine-1-carboxylate (Doripenem side-chain)
CAS:127626-37-3; 491878-06-9	有效期: 一年

Doripenem side-chain intermediate: (2S,4R)-2-(hydroxymethyl)-4-[(methylsulfonyl)oxy]-1-Pyrrolidinecarboxylic acid,(4-nitrophenyl)methyl ester CAS No.: 127626-37-3 Doripenem side-chain: 4-Nitrobenzyl(2S,4S)-4-acetylthio-2-[[N-sulfamoyl-N-(tert-butoxycarbonyl)amino]methyl]pyrrolidine-1-carboxylate CAS No.: 491878-06-9

關(guān)鍵字： 127626-37-3; 491878-06-9

公司簡(jiǎn)介

Established in 2000, Beijing Lunarsun Pharmaceutical Co., Ltd is an emerging specialized pharmaceutical company with the head office located in Beijing. Lunarsun Pharma comprises of one new-drug research institute in Beijing (Beijing Saintsun Pharmaceutical Institute), two chemical factories in Jiangsu Province (Jiangsu Chemstar Industrials Co., Ltd.) and Hebei province and one GMP production base in Chongqing (Chongqing Lummy Pharmaceutical Co., Ltd.).

成立日期		注冊(cè)資本
員工人數(shù)		年?duì)I業(yè)額
主營(yíng)行業(yè)		經(jīng)營(yíng)模式

北京萊瑞森醫(yī)藥有限公司

非會(huì)員

公司成立：暫無(wú)
注冊(cè)資本：暫無(wú)
企業(yè)類型：暫無(wú)
主營(yíng)產(chǎn)品：暫無(wú)
公司地址：Building No.18, Yard No.11, Xisha Industrial Zone, Beiqijia Town, Changping District, Beijing, China

進(jìn)入店鋪

詢盤

店內(nèi)推薦

法羅培南鈉

詢價(jià)

多尼培南

詢價(jià)

帕尼培南

詢價(jià)